BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

820 related articles for article (PubMed ID: 27162535)

  • 1. Phase I/II Trial Evaluating Carbon Ion Radiotherapy for Salvaging Treatment of Locally Recurrent Nasopharyngeal Carcinoma.
    Kong L; Hu J; Guan X; Gao J; Lu R; Lu JJ
    J Cancer; 2016; 7(7):774-83. PubMed ID: 27162535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase I/II trial evaluating concurrent carbon-ion radiotherapy plus chemotherapy for salvage treatment of locally recurrent nasopharyngeal carcinoma.
    Kong L; Gao J; Hu J; Hu W; Guan X; Lu R; Lu JJ
    Chin J Cancer; 2016 Dec; 35(1):101. PubMed ID: 28007028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes of carbon-ion radiotherapy for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Gao J; Guan X; Hu W; Yang J; Qiu X; Chen M; Kong L; Lu JJ
    Cancer; 2020 Dec; 126(23):5173-5183. PubMed ID: 32931035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvage Carbon Ion Radiation Therapy for Locally Recurrent or Radiation-Induced Second Primary Sarcoma of the Head and Neck.
    Yang J; Gao J; Wu X; Hu J; Hu W; Kong L; Lu JJ
    J Cancer; 2018; 9(12):2215-2223. PubMed ID: 29937942
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial.
    Combs SE; Kieser M; Habermehl D; Weitz J; Jäger D; Fossati P; Orrechia R; Engenhart-Cabillic R; Pötter R; Dosanjh M; Jäkel O; Büchler MW; Debus J
    BMC Cancer; 2012 Apr; 12():137. PubMed ID: 22472035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salvage treatment using carbon ion radiation in patients with locoregionally recurrent nasopharyngeal carcinoma: Initial results.
    Hu J; Bao C; Gao J; Guan X; Hu W; Yang J; Hu C; Kong L; Lu JJ
    Cancer; 2018 Jun; 124(11):2427-2437. PubMed ID: 29579324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomised phase I/II study to evaluate carbon ion radiotherapy versus fractionated stereotactic radiotherapy in patients with recurrent or progressive gliomas: the CINDERELLA trial.
    Combs SE; Burkholder I; Edler L; Rieken S; Habermehl D; Jäkel O; Haberer T; Haselmann R; Unterberg A; Wick W; Debus J
    BMC Cancer; 2010 Oct; 10():533. PubMed ID: 20925951
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility of Re-irradiation using carbon ions for recurrent head and neck malignancies after carbon-ion radiotherapy.
    Hayashi K; Koto M; Ikawa H; Hagiwara Y; Tsuji H; Ogawa K; Kamada T
    Radiother Oncol; 2019 Jul; 136():148-153. PubMed ID: 31015117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of carbon-ion radiotherapy in the treatment of adenoid cystic carcinoma of the nasopharynx.
    Hu J; Hu W; Gao J; Yang J; Qiu X; Huang Q; Kong L; Lu JJ
    Ann Transl Med; 2022 Nov; 10(22):1198. PubMed ID: 36544666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbon ion radiotherapy boost in the treatment of glioblastoma: a randomized phase I/III clinical trial.
    Kong L; Gao J; Hu J; Lu R; Yang J; Qiu X; Hu W; Lu JJ
    Cancer Commun (Lond); 2019 Feb; 39(1):5. PubMed ID: 30786916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon ion radiotherapy of hepatocellular carcinoma provides excellent local control: The prospective phase I PROMETHEUS trial.
    Hoegen-Saßmannshausen P; Naumann P; Hoffmeister-Wittmann P; Ben Harrabi S; Seidensaal K; Weykamp F; Mielke T; Ellerbrock M; Habermehl D; Springfeld C; Dill MT; Longerich T; Schirmacher P; Mehrabi A; Chang DH; Hörner-Rieber J; Jäkel O; Haberer T; Combs SE; Debus J; Herfarth K; Liermann J
    JHEP Rep; 2024 Jun; 6(6):101063. PubMed ID: 38737600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of carbon ion radiotherapy for unresectable locally recurrent rectal cancer: a single institutional experience.
    Cai X; Du Y; Wang Z; Li P; Yu Z; Zhang Q; Zhang Z
    Radiat Oncol; 2020 Aug; 15(1):209. PubMed ID: 32859234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bimodal Radiotherapy with Active Raster-Scanning Carbon Ion Radiotherapy and Intensity-Modulated Radiotherapy in High-Risk Nasopharyngeal Carcinoma Results in Excellent Local Control.
    Akbaba S; Held T; Lang K; Forster T; Federspil P; Herfarth K; Häfner M; Plinkert P; Rieken S; Debus J; Adeberg S
    Cancers (Basel); 2019 Mar; 11(3):. PubMed ID: 30884910
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbon-ion radiotherapy in the treatment of radiation-induced second primary malignancies.
    Yang J; Gao J; Hu J; Hu W; Qiu X; Huang Q; Kong L; Lu JJ
    Ann Transl Med; 2022 Nov; 10(22):1200. PubMed ID: 36544688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mixed Photon and Carbon-Ion Beam Radiotherapy in the Management of Non-Metastatic Nasopharyngeal Carcinoma.
    Hu J; Huang Q; Gao J; Hu W; Yang J; Guan X; Qiu X; Zhang W; Kong L; Lu JJ
    Front Oncol; 2021; 11():653050. PubMed ID: 34367954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determining RBE for development of lung fibrosis induced by fractionated irradiation with carbon ions utilizing fibrosis index and high-LET BED model.
    Zhou C; Jones B; Moustafa M; Yang B; Brons S; Cao L; Dai Y; Schwager C; Chen M; Jaekel O; Chen L; Debus J; Abdollahi A
    Clin Transl Radiat Oncol; 2019 Jan; 14():25-32. PubMed ID: 30511024
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and feasibility of re-irradiation using carbon ions for pancreatic cancer that recurs after carbon-ion radiotherapy.
    Hagiwara Y; Yamada S; Isozaki Y; Takiyama H; Shinoto M; Kawashiro S; Bhattacharyya T; Nemoto K; Tsuji H
    Clin Transl Radiat Oncol; 2021 Jan; 26():24-29. PubMed ID: 33294643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage Carbon-Ion Radiation Therapy For Locoregionally Recurrent Head and Neck Malignancies.
    Gao J; Hu J; Guan X; Yang J; Hu W; Kong L; Lu JJ
    Sci Rep; 2019 Mar; 9(1):4259. PubMed ID: 30862843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A protocol for a randomized trial evaluating the role of carbon-ion radiation therapy plus camrelizumab for patients with locoregionally recurrent nasopharyngeal carcinoma.
    Hu J; Huang Q; Hu W; Gao J; Yang J; Zhang H; Lu JJ; Kong L
    Cancer Med; 2024 Feb; 13(3):e6742. PubMed ID: 38205914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor volume instead of recurrent T category predicts clinical outcome of patients with locally recurrent nasopharyngeal carcinoma salvaged by carbon ion radiation therapy.
    Hu J; Huang Q; Hu W; Liang F; Gao J; Yang J; Qiu X; Zhang H; Zhang G; Lu JJ; Kong L
    Oral Oncol; 2024 Apr; 151():106683. PubMed ID: 38387259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 41.